331 related articles for article (PubMed ID: 38037114)
1. Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges.
Pang Z; Lu MM; Zhang Y; Gao Y; Bai JJ; Gu JY; Xie L; Wu WZ
Biomark Res; 2023 Dec; 11(1):104. PubMed ID: 38037114
[TBL] [Abstract][Full Text] [Related]
2. Neoantigen-targeted TCR-T cell therapy for solid tumors: How far from clinical application.
Xu R; Du S; Zhu J; Meng F; Liu B
Cancer Lett; 2022 Oct; 546():215840. PubMed ID: 35921969
[TBL] [Abstract][Full Text] [Related]
3. Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor-Engineered T Cells for Ovarian Cancer.
Matsuda T; Leisegang M; Park JH; Ren L; Kato T; Ikeda Y; Harada M; Kiyotani K; Lengyel E; Fleming GF; Nakamura Y
Clin Cancer Res; 2018 Nov; 24(21):5357-5367. PubMed ID: 29720506
[No Abstract] [Full Text] [Related]
4. Generation of neoantigen-specific T cells for adoptive cell transfer for treating head and neck squamous cell carcinoma.
Wei T; Leisegang M; Xia M; Kiyotani K; Li N; Zeng C; Deng C; Jiang J; Harada M; Agrawal N; Li L; Qi H; Nakamura Y; Ren L
Oncoimmunology; 2021 May; 10(1):1929726. PubMed ID: 34104546
[TBL] [Abstract][Full Text] [Related]
5. Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia.
Zhou W; Yu J; Li Y; Wang K
Exp Hematol Oncol; 2022 Nov; 11(1):100. PubMed ID: 36384590
[TBL] [Abstract][Full Text] [Related]
6. A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigens.
Hu Z; Anandappa AJ; Sun J; Kim J; Leet DE; Bozym DJ; Chen C; Williams L; Shukla SA; Zhang W; Tabbaa D; Steelman S; Olive O; Livak KJ; Kishi H; Muraguchi A; Guleria I; Stevens J; Lane WJ; Burkhardt UE; Fritsch EF; Neuberg D; Ott PA; Keskin DB; Hacohen N; Wu CJ
Blood; 2018 Nov; 132(18):1911-1921. PubMed ID: 30150207
[TBL] [Abstract][Full Text] [Related]
7. Evolution of CD8
Sun Y; Li F; Sonnemann H; Jackson KR; Talukder AH; Katailiha AS; Lizee G
Cells; 2021 Sep; 10(9):. PubMed ID: 34572028
[TBL] [Abstract][Full Text] [Related]
8. Direct identification of neoantigen-specific TCRs from tumor specimens by high-throughput single-cell sequencing.
Lu YC; Zheng Z; Lowery FJ; Gartner JJ; Prickett TD; Robbins PF; Rosenberg SA
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34321276
[TBL] [Abstract][Full Text] [Related]
9. Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma.
Ren L; Leisegang M; Deng B; Matsuda T; Kiyotani K; Kato T; Harada M; Park JH; Saloura V; Seiwert T; Vokes E; Agrawal N; Nakamura Y
Oncoimmunology; 2019; 8(4):e1568813. PubMed ID: 30906664
[TBL] [Abstract][Full Text] [Related]
10. Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies.
Kast F; Klein C; Umaña P; Gros A; Gasser S
Oncoimmunology; 2021 Jan; 10(1):1869389. PubMed ID: 33520408
[TBL] [Abstract][Full Text] [Related]
11. Identification of T Cell Receptors Targeting a Neoantigen Derived from Recurrently Mutated FGFR3.
Tate T; Matsumoto S; Nemoto K; Leisegang M; Nagayama S; Obama K; Nakamura Y; Kiyotani K
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831375
[TBL] [Abstract][Full Text] [Related]
12. Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response.
He J; Xiong X; Yang H; Li D; Liu X; Li S; Liao S; Chen S; Wen X; Yu K; Fu L; Dong X; Zhu K; Xia X; Kang T; Bian C; Li X; Liu H; Ding P; Zhang X; Liu Z; Li W; Zuo Z; Zhou P
Cell Res; 2022 Jun; 32(6):530-542. PubMed ID: 35165422
[TBL] [Abstract][Full Text] [Related]
13. Emerging Strategies in TCR-Engineered T Cells.
Wei F; Cheng XX; Xue JZ; Xue SA
Front Immunol; 2022; 13():850358. PubMed ID: 35432319
[TBL] [Abstract][Full Text] [Related]
14. A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers.
Hanada KI; Zhao C; Gil-Hoyos R; Gartner JJ; Chow-Parmer C; Lowery FJ; Krishna S; Prickett TD; Kivitz S; Parkhurst MR; Wong N; Rae Z; Kelly MC; Goff SL; Robbins PF; Rosenberg SA; Yang JC
Cancer Cell; 2022 May; 40(5):479-493.e6. PubMed ID: 35452604
[TBL] [Abstract][Full Text] [Related]
15. Cell surface marker-based capture of neoantigen-reactive CD8
Chatani PD; Lowery FJ; Parikh NB; Hitscherich KJ; Yossef R; Hill V; Gartner JJ; Paria B; Florentin M; Ray S; Bera A; Parkhust M; Robbins P; Krishna S; Rosenberg SA
J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37258038
[TBL] [Abstract][Full Text] [Related]
16. Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects.
Shafer P; Kelly LM; Hoyos V
Front Immunol; 2022; 13():835762. PubMed ID: 35309357
[TBL] [Abstract][Full Text] [Related]
17. Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells.
Kato T; Matsuda T; Ikeda Y; Park JH; Leisegang M; Yoshimura S; Hikichi T; Harada M; Zewde M; Sato S; Hasegawa K; Kiyotani K; Nakamura Y
Oncotarget; 2018 Feb; 9(13):11009-11019. PubMed ID: 29541393
[TBL] [Abstract][Full Text] [Related]
18. Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy.
Shah RK; Cygan E; Kozlik T; Colina A; Zamora AE
Front Immunol; 2023; 14():1301100. PubMed ID: 38149253
[TBL] [Abstract][Full Text] [Related]
19. The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells.
Li J; Xiao Z; Wang D; Jia L; Nie S; Zeng X; Hu W
Mol Cancer; 2023 Aug; 22(1):141. PubMed ID: 37649123
[TBL] [Abstract][Full Text] [Related]
20. Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma.
Bräunlein E; Lupoli G; Füchsl F; Abualrous ET; de Andrade Krätzig N; Gosmann D; Wietbrock L; Lange S; Engleitner T; Lan H; Audehm S; Effenberger M; Boxberg M; Steiger K; Chang Y; Yu K; Atay C; Bassermann F; Weichert W; Busch DH; Rad R; Freund C; Antes I; Krackhardt AM
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34518289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]